Research Article
Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets
Table 4
Experimental levels of the independent variables for optimizing the fixed-dose combination of metformin HCl and glibenclamide orodispersible tablets.
| |||||||||||||||||||||||||||||||||||||||||||||||
α = 1.68179. |